APA

Howarth J. L., Kelly S., Keasey M. P., Glover C. P. J., Lee Y., Mitrophanous K., Chapple J. P., Gallo J. M., Cheetham M. E. & Uney J. B. (20070925). Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease. : Molecular therapy : the journal of the American Society of Gene Therapy.

Chicago

Howarth J L, Kelly S, Keasey M P, Glover C P J, Lee Y-B, Mitrophanous K, Chapple J P, Gallo J M, Cheetham M E and Uney J B. 20070925. Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease. : Molecular therapy : the journal of the American Society of Gene Therapy.

Harvard

Howarth J. L., Kelly S., Keasey M. P., Glover C. P. J., Lee Y., Mitrophanous K., Chapple J. P., Gallo J. M., Cheetham M. E. and Uney J. B. (20070925). Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease. : Molecular therapy : the journal of the American Society of Gene Therapy.

MLA

Howarth J L, Kelly S, Keasey M P, Glover C P J, Lee Y-B, Mitrophanous K, Chapple J P, Gallo J M, Cheetham M E and Uney J B. Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease. : Molecular therapy : the journal of the American Society of Gene Therapy. 20070925.